Adiponectin circulating levels and 10-year (2002–2012) cardiovascular disease incidence: the ATTICA Study

[1]  A. Khera,et al.  Sex-Based Differences in Cardiometabolic Biomarkers , 2017, Circulation.

[2]  Ioannis Kyrou,et al.  Fat Hormones, Adipokines , 2017 .

[3]  F. Tinahones,et al.  Does Metabolically Healthy Obesity Exist? , 2016, Nutrients.

[4]  S. Kidambi,et al.  Adiponectin Levels Differentiate Metabolically Healthy vs Unhealthy Among Obese and Nonobese White Individuals. , 2015, The Journal of clinical endocrinology and metabolism.

[5]  Z. Daniil,et al.  Effects of smoking cessation on serum leptin and adiponectin levels , 2015, Tobacco induced diseases.

[6]  M. Fasshauer,et al.  Adipokines in health and disease. , 2015, Trends in pharmacological sciences.

[7]  A. Schoenenberger,et al.  Gender-Specific Associations between Circulating T-Cadherin and High Molecular Weight-Adiponectin in Patients with Stable Coronary Artery Disease , 2015, PloS one.

[8]  T. Länne,et al.  Gender difference in adiponectin associated with cardiovascular mortality , 2015, BMC Medical Genetics.

[9]  D. Panagiotakos,et al.  Ten-year (2002-2012) cardiovascular disease incidence and all-cause mortality, in urban Greek population: the ATTICA Study. , 2015, International journal of cardiology.

[10]  F. Hu,et al.  Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism , 2014, Cardiovascular Diabetology.

[11]  J. Kizer.  Adiponectin, cardiovascular disease, and mortality: parsing the dual prognostic implications of a complex adipokine. , 2014, Metabolism: clinical and experimental.

[12]  A. D'Amico,et al.  Back to the heart: the protective role of adiponectin. , 2014, Pharmacological research.

[13]  M. Schulze,et al.  Adiponectin and Risk of Stroke: Prospective Study and Meta-analysis , 2014, Stroke.

[14]  K. Walsh,et al.  Cardiometabolic effects of adiponectin. , 2014, Best practice & research. Clinical endocrinology & metabolism.

[15]  T. Kadowaki,et al.  Adiponectin receptors: a review of their structure, function and how they work. , 2014, Best practice & research. Clinical endocrinology & metabolism.

[16]  Eugene Kim,et al.  Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis. , 2013, International journal of epidemiology.

[17]  Michael J Blaha,et al.  High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? , 2013, Journal of the American College of Cardiology.

[18]  L. Kappelle,et al.  Adiponectin and incident coronary heart disease and stroke. A systematic review and meta‐analysis of prospective studies , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[19]  K. Yamagishi,et al.  Total and high molecular weight adiponectin levels and risk of cardiovascular disease in individuals with high blood glucose levels. , 2013, Atherosclerosis.

[20]  Jie Cao,et al.  Adiponectin Levels and Risk of Coronary Heart Disease: A Meta-analysis of Prospective Studies , 2013, The American journal of the medical sciences.

[21]  B. Zhang,et al.  Serum total adiponectin level and risk of cardiovascular disease in Han Chinese populations: a meta‐analysis of 17 case–control studies , 2012, Clinical endocrinology.

[22]  P. Scherer,et al.  Adiponectin: mechanistic insights and clinical implications , 2012, Diabetologia.

[23]  K. Kotani,et al.  Adiponectin and smoking status: a systematic review. , 2012, Journal of atherosclerosis and thrombosis.

[24]  C. Rotimi,et al.  Paradoxical Hyperadiponectinemia is Associated With the Metabolically Healthy Obese (MHO) Phenotype in African Americans. , 2012, Journal of endocrinology and metabolism.

[25]  H. Cena,et al.  Relationship between smoking and metabolic syndrome. , 2011, Nutrition reviews.

[26]  N. Cook,et al.  High-Molecular-Weight and Total Adiponectin Levels and Incident Symptomatic Peripheral Artery Disease in Women: A Prospective Investigation , 2011, Circulation.

[27]  J. Manson,et al.  Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women. , 2011, Atherosclerosis.

[28]  L. Chuang,et al.  Smokers show reduced circulating adiponectin levels and adiponectin mRNA expression in peripheral blood mononuclear cells. , 2011, Atherosclerosis.

[29]  J. Després,et al.  Adiponectin and risk of coronary heart disease in apparently healthy men and women (from the EPIC-Norfolk Prospective Population Study). , 2011, The American journal of cardiology.

[30]  P. Wilson,et al.  Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham offspring Study. , 2011, Atherosclerosis.

[31]  S. Daniels,et al.  Paradoxically high adiponectin in obese 16-year-old girls protects against appearance of the metabolic syndrome and its components seven years later. , 2011, The Journal of pediatrics.

[32]  P. Ruiz-Lozano,et al.  T-cadherin is critical for adiponectin-mediated cardioprotection in mice. , 2010, The Journal of clinical investigation.

[33]  S. Daniels,et al.  Paradoxically high adiponectin and the healthy obese phenotype in obese black and white 16-year-old girls. , 2010, Translational research : the journal of laboratory and clinical medicine.

[34]  A. Baird,et al.  High-Molecular-Weight Adiponectin and Incident Ischemic Stroke in Postmenopausal Women: A Women's Health Initiative Study , 2010, Stroke.

[35]  J. Whitehead,et al.  Adiponectin--it's all about the modifications. , 2010, The international journal of biochemistry & cell biology.

[36]  G. Steinberg,et al.  Adipose tissue as an endocrine organ , 2010, Molecular and Cellular Endocrinology.

[37]  V. Bordignon,et al.  Adiponectin action from head to toe , 2010, Endocrine.

[38]  Angelos Evangelou,et al.  Reliability measures of the short International Physical Activity Questionnaire (IPAQ) in Greek young adults. , 2009, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[39]  S. Ishikawa,et al.  Plasma Adiponectin Level and Myocardial Infarction: the JMS Cohort Study , 2009, Journal of epidemiology.

[40]  S. Cummings,et al.  Association of adiponectin with mortality in older adults: the Health, Aging, and Body Composition Study , 2009, Diabetologia.

[41]  C. Aguilar-Salinas,et al.  High adiponectin concentrations are associated with the metabolically healthy obese phenotype. , 2008, The Journal of clinical endocrinology and metabolism.

[42]  V. Rajapurohitam,et al.  Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart. , 2008, Cardiovascular research.

[43]  Y. Hattori,et al.  High molecular weight adiponectin activates AMPK and suppresses cytokine‐induced NF‐κB activation in vascular endothelial cells , 2008, FEBS letters.

[44]  D. Lawlor,et al.  High molecular weight adiponectin is not associated with incident coronary heart disease in older women: a nested prospective case-control study. , 2008, The Journal of clinical endocrinology and metabolism.

[45]  S. Ishikawa,et al.  Association of Adiponectin With Cerebrovascular Disease: A Nested Case–Control Study , 2008, Stroke.

[46]  A. Xu,et al.  Post-translational modifications of adiponectin: mechanisms and functional implications. , 2008, The Biochemical journal.

[47]  L. Kuller,et al.  Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome. , 2007, Atherosclerosis.

[48]  S. Kihara,et al.  Adiponectin protects against the development of systolic dysfunction following myocardial infarction. , 2007, Journal of molecular and cellular cardiology.

[49]  B. Goldstein,et al.  Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. , 2007, The Journal of clinical investigation.

[50]  K. Walsh,et al.  Adiponectin actions in the cardiovascular system. , 2007, Cardiovascular research.

[51]  C. Berne,et al.  Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. , 2007, The Journal of clinical endocrinology and metabolism.

[52]  E. Barrett-Connor,et al.  Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. , 2006, American journal of epidemiology.

[53]  C. Rondinone.  Adipocyte-derived hormones, cytokines, and mediators , 2006, Endocrine.

[54]  Christodoulos Stefanadis,et al.  Dietary patterns: a Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk. , 2006, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[55]  C. Meisinger,et al.  Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. , 2006, Journal of the American College of Cardiology.

[56]  Vineet Chopra,et al.  Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. , 2006, European heart journal.

[57]  J. Danesh,et al.  Adiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis , 2006, Circulation.

[58]  K. Walsh,et al.  Cardioprotection by adiponectin. , 2006, Trends in cardiovascular medicine.

[59]  H. Motoshima,et al.  Adiponectin Suppression of High-Glucose–Induced Reactive Oxygen Species in Vascular Endothelial Cells , 2006, Diabetes.

[60]  R. Ahima.  Metabolic Actions of Adipocyte Hormones: Focus on Adiponectin , 2006, Obesity.

[61]  D. Lawlor,et al.  Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. , 2005, The Journal of clinical endocrinology and metabolism.

[62]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[63]  Jan Frystyk,et al.  Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure , 2005, Circulation.

[64]  S. Kihara,et al.  Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2–dependent mechanisms , 2005, Nature Medicine.

[65]  H. Brenner,et al.  Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. , 2005, European heart journal.

[66]  B. Howard,et al.  Adiponectin and coronary heart disease: the Strong Heart Study. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[67]  E. Rimm,et al.  Adiponectin and future coronary heart disease events among men with type 2 diabetes. , 2005, Diabetes.

[68]  H. Lodish,et al.  T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Cynthia J. Girman,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[70]  Hui Chen,et al.  Adiponectin Stimulates Production of Nitric Oxide in Vascular Endothelial Cells* , 2003, Journal of Biological Chemistry.

[71]  D. Panagiotakos,et al.  Epidemiology of cardiovascular risk factors in Greece: aims, design and baseline characteristics of the ATTICA study , 2003, BMC public health.

[72]  S. Kihara,et al.  Association of Hypoadiponectinemia With Coronary Artery Disease in Men , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[73]  NoriyukiOuchi,et al.  Association of Hypoadiponectinemia With Coronary Artery Disease in Men , 2003 .

[74]  M. Matsuda,et al.  Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. , 2002, Diabetes.

[75]  S. Kihara,et al.  Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages , 2001, Circulation.

[76]  S. Kihara,et al.  Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-&kgr;B Signaling Through a cAMP-Dependent Pathway , 2000, Circulation.

[77]  S. Humphries,et al.  Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.

[78]  A Trichopoulou,et al.  Reproducibility and relative validity of an extensive semi-quantitative food frequency questionnaire using dietary records and biochemical markers among Greek schoolteachers. , 1997, International journal of epidemiology.